December 27, 2019

A retrospective study from Yale School of Medicine shows association with overall survival in non-small cell lung cancer (NSCLC) patients treated with PD-1 pathway blockade using a panel of CD8, CD68, PD-L1 in a novel tissue-based multiplex assay

CAMBRIDGE, Mass, November 8, 2018 – Ultivue announced today that the Yale School of Medicine will present data highlighting the utility of a CD8, CD68, PD-L1 […]
December 27, 2019

Unlocking the complexities of cancer biology with BOND RX and Ultivue.

Melbourne, Australia and Cambridge, Massachusetts – October 25, 2018 | Leica Biosystems and Ultivue begin Co-Marketing of UltiMapper™ Assay on the BOND RX enabling single-step automated […]
Contact Us